Free Trial
OTCMKTS:CMXC

Cell MedX (CMXC) Stock Price, News & Analysis

Cell MedX logo
$0.25 0.00 (0.00%)
As of 06/27/2025

About Cell MedX Stock (OTCMKTS:CMXC)

Key Stats

Today's Range
$0.25
$0.25
50-Day Range
$0.22
$0.48
52-Week Range
$0.00
$0.23
Volume
67 shs
Average Volume
20,342 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

Receive CMXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cell MedX and its competitors with MarketBeat's FREE daily newsletter.

CMXC Stock News Headlines

StimCell Energetics Inc. (CMXC)
Cell MedX Corp. (CMXC)
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this means and how everyday investors like you can position themselves to potentially profit. The timing couldn't be more critical
The best cell phone plans in 2024
Cells, organ systems and ecosystems
CMXC Cell MedX Corp.
Cell structure - AQA Microscopes
Cell biology
See More Headlines

CMXC Stock Analysis - Frequently Asked Questions

Cell MedX's stock was trading at $0.4899 at the beginning of the year. Since then, CMXC stock has decreased by 49.0% and is now trading at $0.25.
View the best growth stocks for 2025 here
.

Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cell MedX investors own include Callon Petroleum (CPE), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Himax Technologies (HIMX), Remark (MARK), Microvision (MVIS) and Ritter Pharmaceuticals (RTTR).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Devices
Sub-Industry
Retail
Current Symbol
OTCMKTS:CMXC
Previous Symbol
NASDAQ:CMXC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:CMXC) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners